Stock Events

Stock Events

CRISPR Therapeutics (C2RS34.SA) Q4 2023 Earnings

Feb 21Confirmed

Q4 2023

0.33

2.03

3.73

5.43

Details

Expected EPS

0.3272612863

Actual EPS

5.428610000000001

Surprise EPS

5.1

Surprise Percent

+1,558.8%

Description

⁨CRISPR Therapeutics⁩ (⁦C2RS34.SA⁩) has reported earnings of ⁦5.428610000000001⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.